Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

12 Results

Guidelines and Advice

Chemotherapy (i.e., Gemcitabine, Docetaxel Plus Gemcitabine, Doxorubicin, or Trabectedin) for Inoperable, Locally Advanced, Recurrent, or Metastatic Uterine Leiomyosarcoma

Status: Archived
ID: GL 11-11

Jul 2012

Guidelines and Advice

Computerized Prescriber Order Entry (CPOE) in the Outpatient Oncology Setting

Status: Current
ID: 12-14

May 2012

Guidelines and Advice

Chemotherapy or Radiotherapy for Resectable Pancreatic Adenocarcinoma

Status: Archived
ID: 2-23
Version: 2-23 Version 2

Oct 2015

Guidelines and Advice

Colorectal Cancer Screening in Average Risk Populations: Evidence Summary

Status: Current
ID: 15-14

Nov 2015

Guidelines and Advice

Cross-Sectional Imaging in Colorectal Cancer

Status: Archived
ID: DICRC

Sep 2012

Guidelines and Advice

Cross-Sectional Diagnostic Imaging in Lung Cancer

Status: Archived
ID: DILung

Apr 2012

Statistical Reports

Cancer in the Métis People of Ontario: Risk Factors and Screening Behaviours

Jul 2015

Statistical Reports

Cancer Risk Factors in Ontario: Healthy Weights, Healthy Eating and Active Living

Mar 2015

Cancer facts

Cancers Related to Excess Body Weight on the Rise in Ontario

Dec 2015

Guidelines and Advice

Cancer Care Ontario’s Position Statement on Guidelines for Breast Cancer Well Follow-Up Care

Status: Current

Dec 2012

Guidelines and Advice

Cancer Care Ontario’s Focus on Take-Home Cancer Drugs and Community Practice

Status: Current
ID: GL-C50-17

Jan 2015

Guidelines and Advice

Clinical Verification of Cancer Drug Prescriptions Checklist: Cancer Centres and Specialty Pharmacies

Status: Current
ID: GL-C50-18

Jan 2015